Reading proliferation without over-reading it: why a ki67 antibody, the ki-67 antibody and ki 67 antibody spellings beside it and an anti ki67 antibody all report cycling rather than division rate, what pcna antibodies and an anti-pcna antibody add and where they disagree, how an mcm2 antibody, a geminin antibody and a cdt1 antibody report licensing and phase rather than activity, what a cyclin d antibody, a cyclin d1 antibody, a cyclin b antibody, a cyclin e antibody and a cyclin h antibody each mark in the cycle, where a cdk1 antibody, a cdk4 antibody, a cdk7 antibody and a cdk9 antibody stop being cycle reagents and start being transcription reagents, what a p21 antibody, the p21 antibodies sold beside it, a p27 antibody and a p16 antibody report about arrest, how a plk1 antibody, a plk4 antibody, an aurora b antibody and a cdc20 antibody mark mitosis specifically, and where a top2a antibody and a foxm1 antibody sit as proliferation associated rather than proliferation defining

A proliferation marker tells you a cell is not resting. It does not tell you how fast the population divides, and several of the most used markers persist well past the event they mark. Reading them as a rate, or treating two of them as interchangeable, produces conclusions the staining cannot support. This page is about what each one actually reports.

good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on an antibody
809.10(c)
the biosafety manual that decides handling for primary material
BMBL

The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

Choosing and reading the marker

  1. Decide whether you need cycling or division. Markers of the cycling state identify cells that are not quiescent. Measuring division requires incorporating a label over a defined window, which is a different experiment with a different reagent and a denaturation step.
  2. Match the marker to the phase you care about. Licensing factors, phase specific cyclins and mitotic kinases each peak at different points. A marker chosen without regard to phase gives a number that mixes populations and cannot be compared across conditions that shift the distribution.
  3. Fix fixation and retrieval per reagent. Nuclear proliferation markers are sensitive to fixation time and retrieval conditions, and a weak stain is far more often a retrieval problem than a reagent problem. Optimise on a tissue known to be proliferating.
  4. Score consistently and say how. Percentage of positive nuclei, intensity thresholds and how partially stained nuclei are treated all change the number. Fix the scoring rule, apply it blind, and state it with the result.
  5. Include an arrested control. A serum starved or confluent population gives the low end of the scale and shows the stain is reporting biology rather than background. It costs one well and settles most disputes about a threshold.

Persistence is what misleads

Several widely used proliferation markers remain detectable for a period after a cell leaves the cycle. In a tissue where cells are entering and leaving continuously, that lag inflates the apparent fraction and does so differently in different tissues.

Where the comparison matters, pair the marker with a phase specific reagent or with an incorporation experiment. The two together bound the answer in a way neither does alone.

Scoring is where the variance lives

Two people scoring the same section can differ substantially, and automated scoring differs again depending on threshold and segmentation. This variability usually exceeds the biological effect being measured.

Write the scoring rule down, validate it on a set both scorers assess, and keep the images. It converts an argument about impressions into a number with a method attached.

Common questions

Does a proliferation index measure growth rate?
No. It measures the fraction of cells in cycle at one moment. A population with a long cycle can show a high index and divide slowly, which is why comparing indices between very different cell types is unsafe.
Why do two proliferation markers disagree?
Because they mark different things: one may persist after the cycle stops, another may be degraded rapidly at a specific phase. Disagreement is usually informative rather than an error.
When is nucleotide incorporation the better choice?
When the question is how many cells divided during a defined window, rather than how many were in cycle when the sample was taken. It requires the label, the exposure window and a denaturation step the marker stains do not.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/ki67-antibody/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices